grant

Analysis of the apoptotic and therapeutic effects of histone deacetylase inhibitors on multiple myeloma [ 2008 - 2011 ]

Also known as: Analysis of new anti-cancer agents for the treatment of multiple myeloma

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/520303]

Researchers: Dr Geoffrey Matthews (Principal investigator)

Brief description Multiple myeloma (MM) is an incurable progressive cancer of plasma cells within blood. It is the second most common blood cancer and represents 2% of all cancer-related deaths. Statistics show increasing incidence and decreasing age of onset. The cause and progression of MM is poorly understood and current treatments are frequently followed by relapse. This project will assess exciting new therapies against the survival of MM cells leading to more effective treatments in the future.

Funding Amount $AUD 287,321.14

Funding Scheme Early Career Fellowships

Notes Peter Doherty Biomedical ECF

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]
ACN 633 798 857